Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 2. ASA- I and III 3. Patients undergoing spine surgery ( intraspinal tumors, tethered spinal cord, spinal cord stenosis, fracture of the vertebral body, scoliosis correction, ossification of the posterior spinal ligament ) with TceMEP monitoring 4. Patients with bilateral upper and lower limb motor function >=4/5 grade of Medical Research Council (MRC) Scale
Exclusion criteria
Exclusion criteria: 1. severe cardiovascular diseases (such as heart block, heart failure, left ventricular dysfunction) 2. significant pulmonary, renal, hepatic or neuromuscular disease, 3. contraindications for MEP monitoring such as epilepsy, cortical lesion, raised intracranial tension, cardiac diseases, intracranial electrodes, vascular clips/shunts, 4. history of chronic alcohol use 5. Anaemia , Hb 6. defined allergy to any of study drugs 7. BMI >30 kg/m2
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. To assess the effect of ketamine and dexmedetomidine infusion on amplitude of MEP 2. To assess the effect of ketamine and dexmedetomidine infusion on latency of MEP Timepoint: intraoperative period at 30 minutes interval and at the end of surgical intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Changes in perioperative hemodynamic parameters 2. Dosage of propofol used 3. Total opoids requirement in intraoperative period 4. Effect on extubation parameter in term of Emergence and extubation time 5. Pain assessment in postoperative period and postoperative analgesic requirement for 1st 24 hours 6. Post operative complications if any Timepoint: in intraoperative and postoperative period | — |
Countries
India
Contacts
AIIMS, rishikesh